VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
This Quarter Return
+7.81%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$753M
AUM Growth
+$753M
(+5.8%)
Cap. Flow
+$5.37M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
7.71%
Holding
486
New
110
Increased
121
Reduced
151
Closed
98
Top Buys
| 1 |
FNSR
Finisar Corp
FNSR
|
$3.66M |
| 2 |
S
Sprint Corporation
S
|
$3.25M |
| 3 |
RAX
Rackspace Hosting Inc
RAX
|
$3.13M |
| 4 |
Credicorp
BAP
|
$3.11M |
| 5 |
TTM
Tata Motors Limited
TTM
|
$3.02M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$4.8M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
$4.17M |
| 3 |
Meta Platforms (Facebook)
META
|
$4.13M |
| 4 |
VA
Virgin America Inc.
VA
|
$3.43M |
| 5 |
United Airlines
UAL
|
$3.32M |
Sector Composition
| 1 | Technology | 15.47% |
| 2 | Healthcare | 12.36% |
| 3 | Financials | 10.67% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Industrials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Designer Brands
DBI
$181M
| $934K | 0.12% |
45,620
+1,313
| +3% | +$26.9K |
|
302
Emergent Biosolutions
EBS
$443M
| $872K | 0.12% |
+27,644
| New | +$872K |
|
303
Merck
MRK
$210B
| $865K | 0.11% |
13,855
+142
| +1% | +$8.87K |
|
|
ADXS
304
DELISTED
Advaxis, Inc.
ADXS
| $864K | 0.11% |
80,825
+982
| +1% | +$10.5K |
|
305
Icon
ICLR
$13.8B
| $843K | 0.11% |
10,898
-156
| -1% | -$12.1K |
|
|
BMCH
306
DELISTED
BMC Stock Holdings, Inc
BMCH
| $823K | 0.11% |
+46,441
| New | +$823K |
|
307
AstraZeneca
AZN
$248B
| $806K | 0.11% |
24,514
-123
| -0.5% | -$4.04K |
|
|
CELG
308
DELISTED
Celgene Corp
CELG
| $796K | 0.11% |
6,193
-6,114
| -50% | -$786K |
|
309
MacroGenics
MGNX
$112M
| $795K | 0.11% |
26,583
-900
| -3% | -$26.9K |
|
310
ImmunityBio
IBRX
$2.21B
| $792K | 0.11% |
101,847
-653
| -0.6% | -$5.08K |
|
|
KDNY
311
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $721K | 0.1% |
57,990
-2,308
| -4% | -$28.7K |
|
|
KITE
312
DELISTED
Kite Pharma, Inc.
KITE
| $721K | 0.1% |
12,904
-243
| -2% | -$13.6K |
|
313
Iovance Biotherapeutics
IOVA
$807M
| $719K | 0.1% |
87,396
+1,689
| +2% | +$13.9K |
|
314
Apple
AAPL
$3.45T
| $707K | 0.09% |
6,253
-15,268
| -71% | -$1.73M |
|
|
ONC
315
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $701K | 0.09% |
22,751
| – | – |
|
316
Atara Biotherapeutics
ATRA
$84.6M
| $700K | 0.09% |
32,721
-158
| -0.5% | -$3.38K |
|
317
Novartis
NVS
$245B
| $696K | 0.09% |
8,809
-44
| -0.5% | -$3.48K |
|
318
Compugen
CGEN
$132M
| $647K | 0.09% |
102,694
+22,200
| +28% | +$140K |
|
|
RAVN
319
DELISTED
Raven Industries Inc
RAVN
| $646K | 0.09% |
+28,052
| New | +$646K |
|
320
Wave Life Sciences
WVE
$1.53B
| $628K | 0.08% |
19,342
-12,990
| -40% | -$422K |
|
321
Celldex Therapeutics
CLDX
$1.47B
| $620K | 0.08% |
153,587
+2,944
| +2% | +$11.9K |
|
322
ProShares VIX Short-Term Futures ETF
VIXY
$87.1M
| $614K | 0.08% |
21,684
-29,522
| -58% | -$836K |
|
|
323
Meta Platforms (Facebook)
META
$1.86T
| $613K | 0.08% |
3,589
-24,184
| -87% | -$4.13M |
|
324
Alaunos Therapeutics
TCRT
$4.21M
| $612K | 0.08% |
108,720
-3,436
| -3% | -$19.3K |
|
|
CLLS
325
Cellectis
CLLS
$258M
| $608K | 0.08% |
25,254
| – | – |
|